Hyperphosphorylated tau has a critical role in tauopathies such as Alzheimer’s disease and frontotemporal dementia, impairing neuronal function and eventually leading to neurodegeneration. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.